Merck has inked an exclusive global licensing deal to use PDS Biotechnology’s innovative Versamune nanotechnology platform in Merck’s two investigational antigen-specific cancer immunotherapies that are now in pre-clinical development.
Scientists at the Institute for Bioengineering of Catalonia and the University of Barcelona have partnered with the Centro National de Biotecnologia in Madrid and developed a novel technique for identifying nanoscale objects and viruses using an electrostatic force microscope (EFM).
Novavax, the biopharmaceutical company that develops vaccines for a range of diseases, announced that its Senior Vice President and Chief Medical Officer, Gregory Glenn, M.D., presented the findings of the preclinical and clinical study for Novavax’s respiratory syncytial virus (RSV) vaccine development program at the first conference on Modern Vaccines Adjuvants and Delivery Systems at Copenhagen in Denmark.
A novel biomimetic approach for direct delivery of clot-dissolving nanotherapeutics to the site of obstructed blood vessels has been devised by researchers from Harvard University’s Wyss Institute for Biologically Inspired Engineering.
Professor Hao Yan from the Arizona State University has been granted a research reward of US $6.25 million to be dispersed over a five-year period by the Department of Defense (DoD) under its Multidisciplinary University Research Initiative (MURI) program.
A team of researchers from the fields of nanotechnology and dermatology has used commercial moisturizers based on a nanostructure platform to provide gene regulation technology, which shows promise in developing life-saving therapies to treat skin cancers.
Researchers at Vanderbilt University have developed a method to tag a protein called the serotonin transporter in human beings at the molecular level. Serotonin is a hormone that regulates appetite, mood and sleep in humans.
Engineering Conferences International (ECI) will be hosting a conference on fibrous protein nanocomposites from October 7 to 12, 2012. It is a multidisciplinary conference that turns the spotlight on the design, characterization and development of bio-nano hybrid materials that have applications in both nanomedicine and electronics.
Chemists at Boston College have made use of silicon nanowires to emulate a process similar to photosynthesis for collecting solar energy in order to power reactions that synthesize the basic compounds employed in two well known anti-inflammatory pain killers.
In a boost to localized disease treatment, research has yielded micro and nano-scale protein making machinery in capsule form, capable of manufacturing drugs inside the human body. The study was published in American Chemical Society’s (ACS) journal, Nano Letters. Proteins are the building blocks of drugs and integral to the human cell.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.